Clinical trial
Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine
NCT00460759 · Johns Hopkins University, Other · Terminated
Key facts
| NCT number | NCT00460759 |
|---|---|
| Title | Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine |
| Official title | Pharmacokinetic Issues in the Use of Moxifloxacin Plus Rifapentine |
| Lead sponsor | Johns Hopkins University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Mycobacterium Tuberculosis |
| Intervention type | Drug |
| Interventions | Moxifloxacin, Rifapentine |
| Enrollment | 15 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 24, 2008 |
| Completion | Aug 24, 2008 |
| First posted | Apr 16, 2007 |
| Last update posted | Dec 7, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: